National Bank of Canada’s Insmed INSM Stock Holding History

National Bank of Canada’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Sell	16,886 -87,872	-84%	-$10.6M	﹤0.01%	1149
2026 Q1	$17.1M	Sell	104,758 -3,948	-4%	-$607K	0.02%	534
2025 Q4	$18.9M	Buy	108,706 +106,225	+4,282%	+$19.4M	0.02%	530
2025 Q3	$357K	Sell	2,481 -43	-2%	-$5.27K	﹤0.01%	1414
2025 Q2	$254K	Buy	2,524 +911	+56%	+$69.7K	﹤0.01%	1554
2025 Q1	$123K	Sell	1,613 -55	-3%	-$4.21K	﹤0.01%	1643
2024 Q4	$115K	Buy	1,668 +147	+10%	+$10.6K	﹤0.01%	1732
2024 Q3	$111K	Sell	1,521 -479	-24%	-$35.3K	﹤0.01%	1508
2024 Q2	$133K	Sell	2,000 -2,000	-50%	-$77.6K	﹤0.01%	1421
2024 Q1	$104K	Hold	4,000	–	–	﹤0.01%	1547
2023 Q4	$120K	Hold	4,000	–	–	﹤0.01%	1532
2023 Q3	$101K	Sell	4,000 -280	-7%	-$6.4K	﹤0.01%	1617
2023 Q2	$90.2K	Hold	4,280	–	–	﹤0.01%	1621
2023 Q1	$72.8K	Buy	4,280 +4,000	+1,429%	+$77.7K	﹤0.01%	1601
2022 Q4	$5.59K	Hold	280	–	–	﹤0.01%	2307
2022 Q3	$6K	Hold	280	–	–	﹤0.01%	2307
2022 Q2	$6K	Buy	280 +50	+22%	+$1.05K	﹤0.01%	2382
2022 Q1	$5K	Buy	230 +85	+59%	+$1.98K	﹤0.01%	2548
2021 Q4	$4K	Buy	+145	New	+$4.15K	﹤0.01%	2581

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

National Bank of Canada's INSM Position: Q2 2026 in Review

National Bank of Canada reduced its Insmed (INSM) stake by 84% in Q2 2026, selling an estimated $10.6M and leaving 16,886 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

National Bank of Canada first reported a position in INSM in Q4 2021 and has held it in 19 quarters since. The position peaked at $18.9M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

National Bank of Canada held 16,886 shares of Insmed worth $1.8M as of Q2 2026.
National Bank of Canada sold 87,872 Insmed shares in Q2 2026, an estimated $10.6M.
Insmed made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #1149 holding.
National Bank of Canada first reported a position in Insmed in Q4 2021 and has held it in 19 quarters since.
National Bank of Canada's Insmed position peaked at $18.9M in Q4 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.